Company*
(Country;
Symbol)		 Company Type/Product Area Terms/Details (Date)
Anavex Life
Sciences Corp.*		 Alexandre
Vamvakides		 Agreement for rights to a portfolio of three patents and one patent application covering drug candidates targeting neurological diseases and cancer Anavex agreed to pay for the development of the compounds by spending not less than $200,000 per year (1/31)
Debiopharm
Group* (Switzerland)		 Kirin Brewery Co. Ltd. (Japan) Exclusive agreement for Debio-0719, an inhibitor of lysophosphatidic acid signaling Debiopharm will manage and fund development before out-licensing to sales and marketing partners in all territories outside of Asia, where Kirin will maintain rights; Kirin will receive milestone payments and royalties (1/30)
Integrated
Genomics Inc.*		 Arla Foods amba (Denmark) Agreement to sequence and analyze lactic acid bacterium Financial terms were not disclosed (1/30)
Napo
Pharmaceuticals
Inc. (LSE:NAPL)		 Nicholas Piramal India Ltd. (India) Plant screening agreement to discover diabetes thera-peutic agents The companies will jointly own all products developed (1/22)
New Life
Scientific Inc.
(OTC BB:NWLS)		 N/A Exclusive license agreement for two platform technologies allowing for the formulation of topical drugs The first technology involves topical formulation of prostaglandins, which will be used to develop treatments for erectile dysfunction, female sexual arousal disorder and for wound healing; the second technology is designed for enhanced drug bioavailability and will be used to increase concentrations of drugs for skin and nail fungal infections and other indications (1/16)
Sequenom Inc.
(SQNM)		 Lenetix Medical Screening Laboratory Inc. Partnership to develop and commercialize a non-invasive prenatal Rhesus D incompatibility test based on Sequenom patent rights and RT PCR methodology Financial terms were not disclosed (1/29)
Notes:
* Private companies are indicated with an asterisk. N/A = Not available.
Unless otherwise noted, the trading symbols listed for public companies are on the Nasdaq market.
LSE = London Stock Exchange; OTC BB = Over-the-Counter Bulletin Board.